Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study

L Mathieson, A Severn, B Guthrie

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    To determine whether angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) initiation in people with diabetes is monitored as recommended by recent guidelines and the incidence of associated adverse renal events.
    Original languageEnglish
    Pages (from-to)69-76
    Number of pages8
    JournalScottish Medical Journal
    Volume58
    Issue number2
    DOIs
    Publication statusPublished - May 2013

    Keywords

    • Aged
    • Aged, 80 and over
    • Analysis of Variance
    • Angiotensin Receptor Antagonists
    • Angiotensin-Converting Enzyme Inhibitors
    • Creatinine
    • Diabetes Mellitus, Type 2
    • Drug Monitoring
    • Electrolytes
    • Female
    • General Practice
    • Humans
    • Hyperkalemia
    • Logistic Models
    • Male
    • Middle Aged
    • Retrospective Studies

    Fingerprint Dive into the research topics of 'Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study'. Together they form a unique fingerprint.

    Cite this